Mode
Text Size
Log in / Sign up

ZJU index predicts diabetes progression and normoglycemia reversion in 11,243 individuals with impaired fasting glucoseYour Blood Sugar Future May Be Predictable Sooner Than You Think

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that the ZJU index associates with diabetes progression and normoglycemia reversion in impaired fasting glucose.

This retrospective multicenter cohort study included 11,243 individuals with impaired fasting glucose enrolled in a health screening program. The primary outcomes assessed were progression to diabetes and reversion to normoglycemia. Safety data, including adverse events and tolerability, were not reported in this analysis.

Results indicated that each one-unit increase in the ZJU index was associated with a 3% lower hazard of reversion to normoglycemia. Conversely, each one-unit increase in the ZJU index was associated with a 12% higher hazard of progression to diabetes. Absolute numbers and p-values were not reported for these associations.

The study did not report safety outcomes, discontinuations, or specific tolerability profiles for the index application. Limitations include the observational nature of the design and the absence of reported follow-up duration. Consequently, causal inferences cannot be drawn, and the findings should be viewed as associations rather than definitive clinical effects.

Despite these limitations, the ZJU index can serve as a practical tool for risk stratification and precision management in clinical settings. Clinicians should interpret these hazard ratios with caution given the lack of randomized evidence and missing safety data.

  • High ZJU score? Higher diabetes risk, lower chance of recovery
  • Helps adults with prediabetes, especially in early stages
  • Not a treatment — but a powerful warning sign already in use

This simple number could help stop diabetes before it starts.

You’re 45, feel fine, and your last checkup showed slightly high blood sugar. You’re told to “watch it.” But no one knows if you’ll bounce back — or slide into diabetes.

Now, a new study of over 11,000 people in China may have found a better way to predict what happens next.

Prediabetes means your blood sugar is higher than normal — but not yet diabetic. It’s a quiet warning. And for millions, it’s the last chance to turn things around.

In the U.S., about 1 in 3 adults has prediabetes. Most don’t know it. And globally, numbers keep rising — especially in Asian populations.

Many with prediabetes have impaired fasting glucose (IFG). That means their blood sugar is too high after not eating — usually first thing in the morning. Right now, doctors guess who might get worse. But guesses aren’t enough.

Current tools don’t always catch who’s truly at risk. Some people improve on their own. Others get diabetes within a few years.

We need better ways to tell the difference — fast.

The Surprising Shift

For years, doctors focused on single numbers: weight, blood sugar, cholesterol. They looked at each piece apart.

But the body doesn’t work that way. Metabolism is a system — like a network of roads. One traffic jam can slow everything down.

Scientists now think we need combined scores — tools that look at the whole picture. One of those is the ZJU index.

What’s Different This Time

The ZJU index isn’t new — but how it’s being used is.

It combines routine blood tests: blood sugar, triglycerides, HDL (“good”) cholesterol, and insulin levels. Doctors plug them into a formula. Out comes one number — the ZJU score.

Think of it like a “metabolic report card.” A higher score means more strain on your body’s ability to manage sugar.

But here’s the twist: No one knew how well this score could predict the future for people with IFG — until now.

Your body runs on glucose — sugar from food. But sugar can’t get into cells without insulin, a hormone that acts like a key.

In prediabetes, the “lock” starts to rust. Cells don’t respond well to insulin — this is called insulin resistance.

The pancreas tries to keep up by making more insulin. But over time, it can’t keep pace. Blood sugar rises. Diabetes follows.

The ZJU index measures how hard your body is working — and how close you might be to breaking point.

One Number, Two Futures

The study followed 11,243 Chinese adults with IFG for several years. All had their ZJU index calculated at the start.

Researchers then tracked two things: Did people return to normal blood sugar? Or did they progress to type 2 diabetes?

The results were clear.

People with higher ZJU scores were much less likely to get better on their own. Each one-point rise in the score meant a 3% lower chance of returning to normal.

At the same time, their risk of diabetes went up — by 12% per point.

That’s not just a small bump. It means this one number could help spot who needs help now.

The Threshold That Matters

The study found a turning point — a ZJU score of about 38.5. Below it, people had a real shot at reversing prediabetes.

Above it, the odds shifted sharply. The higher the score, the steeper the climb back.

This wasn’t a straight line. After 38.5, the risk of diabetes rose faster — like a car accelerating downhill.

This doesn’t mean this treatment is available yet.

This isn’t a drug. It’s not a cure. But it could change how doctors manage prediabetes.

Right now, many people get general advice: lose weight, eat better, move more. But not everyone needs the same push.

The ZJU index could help personalize care. High score? You may need early, strong action — like medication or a structured program.

Low score? You might reverse it with lifestyle changes alone.

This study adds to growing proof that combined scores beat single numbers. It fits with other research using tools like the TyG index or metabolic syndrome scores.

Experts say we’re moving toward precision prevention — not guessing, but knowing. And doing it with tests already done in routine checkups.

No extra blood draws. No new machines. Just smarter use of data we already collect.

If you have prediabetes, this score isn’t yet standard in the U.S. or Europe. But it might be soon.

Ask your doctor if your clinic uses metabolic scores like ZJU, TyG, or others. Even better: ask what your risk really is — and how they’re deciding.

Lifestyle changes still work. But knowing your risk level could help you take the right steps — at the right time.

The Catch

This study only included Chinese adults. We don’t yet know if the same threshold (38.5) works for other groups.

Also, it was a retrospective study — meaning it looked back at old data. The next step is testing this in real time — to see if acting on the score actually improves outcomes.

And while the ZJU index uses common tests, not all clinics calculate it automatically. It’s not yet part of most electronic health records.

Researchers need to test this in diverse populations — including Black, Hispanic, and European groups. Future studies will likely track whether using the ZJU index helps people avoid diabetes in real-world care.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundDM is a chronic metabolic disorder with a globally increasing prevalence. IFG, a major subtype of prediabetes, is highly prevalent amongthe Chinese adult population and represents a critical window for therapeutic intervention. The ZJU index is a comprehensive metabolic indicator that reflects systemic insulin resistance and metabolic burden status. However, its association with bidirectional glycemic outcomes specifically in individuals with IFG remains unclear. This study aimed to investigate the impact of the baseline ZJU index on the progression to diabetes, as well as on the reversion to normoglycemia.MethodsThis multicenter retrospective cohort study analyzed data from 11,243 individuals with IFG enrolled in a health screening program between 2010 and 2016. The ZJU index, calculated using a standardized formula, served as the primary exposure variable. We employed Cox proportional hazards regression and logistic regression models to examine the association between the ZJU index and glycemic status transition. RCS was used to explore nonlinear relationships, and a threshold effect analysis was conducted to identify potential inflection points. Subgroup and sensitivity analyses were performed to assess the robustness of the associations.ResultsHigher baseline ZJU index quartiles were significantly associated with a decreased likelihood of reversion to normoglycemia and an increased risk of diabetes progression. In the fully adjusted Cox model, each one-unit increase in the ZJU index was associated with a 3% lower hazard of reversion to normoglycemia and a 12% higher hazard of progression to DM. RCS analysis revealed a linear inverse association with reversion and a nonlinear positive association with progression, with an inflection point at a ZJU index of 38.499. Subgroup and sensitivity analyses confirmed the robustness and consistency of these associations across diverse population strata and data handling methods.ConclusionsIn individuals with IFG, a higher ZJU index demonstrates​ a linear inverse association with reversion to normoglycemia and a non-linear positive association with progression to incident DM. Accordingly, the ZJU index can serve as​ a practical tool for risk stratification and precision management, guiding preventive strategies for those at high risk of DM.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.